Trials / Unknown
UnknownNCT05107388
Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer
AAREN: Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the glycemic profile of postmenopausal women treated with alpelisib plus fulvestrant using a continuous blood sugar monitoring device (FreeStyle Libre Pro) over 14 days
Detailed description
AAREN is a monocentric prospective study monitoring glycemic profile in patients treated with alpelisib plus fulvestrant. Patients will wear a noninvasive glucose monitoring sensor, the Freestyle Libre Pro for a 14 day period. Forty patients will be enrolled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FreeStyle Libre Pro | Measurements of interstitial glucose variations with FreeStyle Libre Pro |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2024-01-01
- Completion
- 2024-03-01
- First posted
- 2021-11-04
- Last updated
- 2021-11-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05107388. Inclusion in this directory is not an endorsement.